Important Note: Specimen Validity Testing

Specimen validity testing is an important part of every urine drug test. It provides clinicians with critical information about the accuracy and reliability of drug test results, and verifies that the specimen submitted is a valid human urine specimen.

All three of these important criteria must fall within the range of normal human urine for a urine sample to be considered valid: Creatinine, Specific Gravity, pH.

Popular Non-DOT Panels

Urine

eCup 5-Panel Instant:
Cannabinoids (THC), Cocaine, Methamphetamine, Opiates, Phencyclidine

—Negative results are returned same day as donation—

xCup 6 to 10-Panel Instant:
Marijuana (THC), Cocaine, Methamphetamine, Opiates, Phencyclidine, Amphetamine, Barbiturates, Benzodiazepines, Methadone, Oxycodone.

—Negative results are returned same day as donation—

5-Panel Lab:
Cannabinoids (THC), Cocaine, Methamphetamine, Opiates, Phencyclidine

—Negative results are returned within 36-72 hours—

10-Panel Lab:
Cannabinoids (THC), Cocaine, Methamphetamine, Opiates, Phencyclidine, Barbiturates, Benzodiazepines, Propoxyphenes, Methadone, Methaqualone

—Negative results are returned within 36-72 hours—

Breath Alcohol

Tests for alcohol levels in the breath

—Results are returned same day—


Standard DOT Panels

Urine

9-panel standard DOT lab
Marijuana (THC), Cocaine, Phencyclidine (PCP), Amphetamines (includes Methamphetamines, MDMA, MDA), Opioids, Codeine/Morphine, 6-AM (Heroin), Hydrocodone/Hydromorphone, Oxycodone/Oxymorphone

—Negative results are returned within 36-72 hours—

Breath Alcohol

Tests for alcohol levels in the breath and meets DOT standards.

—Results are returned same day—

The Department of Transportation expanded its Federal Motor Carrier Safety Administration (FMCSA) mandated drug testing panel, effective 1/1/2018, to include four (4) “semi-synthetic” opioid drugs: hydrocodone, hydromorphone, oxycodone, and oxymorphone.

The addition of the semi-synthetic opioid drugs is intended to address the nationwide epidemic of prescription painkiller abuse. Hydrocodone, hydromorphone, oxycodone and oxymorphone are Schedule II controlled substances and are more commonly known as Vicodin, OxyContin, Lortab, Norco, Percocet and Dilaudid, among others.


Random, Ongoing, and Consortium Panels

The Random, Ongoing, and/or Consortium programs use the same SAMHSA-certified drug panels as the non-DOT and DOT panels. Each company’s specific goals, needs, and policies dictate the panel required.

A drug screening consortium is a collection of various companies with 49 or less employees that need DOT drug and alcohol testing, and/or non-DOT testing. The member companies add their employees to a combined random consortium testing pool.

For 50 or more employees, the company is set up on its own individual random and/or ongoing drug testing program, no consortium enrollment needed.

By using a random selection process, employers ensure that there is no bias and that all employees have an equal chance of being selected.


Reasonable Suspicion and Post-Accident Panels

The Reasonable Suspicion and Post-Accident programs use the same SAMHSA-certified drug panels as the non-DOT and DOT panels. It is the goal, need and policy of the company that dictates the panel required.

“Reasonable Suspicion” testing is based on individualized suspicion of a particular employee believed to be under the influence of alcohol or drugs, in violation of company policy.

“Post-Accident” testing is performed after an employee has been involved in an accident while at work.

Signs of Reasonable Suspicion on the job might include:

  • Bloodshot eyes/dilated pupils
  • Slurred speech
  • Unsteady walk/movements
  • Difficulty staying awake